title: Clearance of Cellulosimicrobium cellulans bacteremia in a child without central venous catheter removal.
abstract: Cellulosimicrobium cellulans (formerly known as Oerskovia xanthineolytica) rarely causes human infection. Infections have been reported in immunocompromised hosts or in patients with foreign bodies, such as catheters, where treatment has generally involved removal of the foreign body. We report on a case in which the organism was isolated in multiple blood cultures from a 13-year-old male. After initial therapy failed, treatment with vancomycin and rifampin resulted in infection clearance without removal of the central venous catheter.
authors.affiliation: UCLA School of Medicine, Department of Pathology and Laboratory Medicine, 10833 LeConte Avenue, Los Angeles, CA 90095-1752, USA.
authors.forename: Marie-Claire
authors.initials: MC
authors.lastname: Rowlinson
authors.forename: David A
authors.initials: DA
authors.lastname: Bruckner
authors.forename: Claudia
authors.initials: C
authors.lastname: Hinnebusch
authors.forename: Karin
authors.initials: K
authors.lastname: Nielsen
authors.forename: Jaime G
authors.initials: JG
authors.lastname: Deville
mesh_terms: D000192:Actinomycetales / Q000302:isolation & purification*; D000193:Actinomycetales Infections / Q000188:drug therapy* / Q000382:microbiology; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D001769:Blood / Q000382:microbiology; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D012293:Rifampin / Q000627:therapeutic use*; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D012293:Rifampin